Arkolith/Insider Trading/REGN/Form 4

Ryan Arthur F

DirectorREGENERON PHARMACEUTICALS, INC. (REGN) · full profile →Form 4 · filed Mar 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$79K
Net Open-Market Flow
-$79K
Transactions
13
13 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 2, 2026Sell(S)20$788.96$16K18K
Mar 2, 2026Sell(S)2$787.34$2K18K
Mar 2, 2026Sell(S)7$786.61$6K18K
Mar 2, 2026Sell(S)11$785.48$9K18K
Mar 2, 2026Sell(S)2$781.21$2K18K
Mar 2, 2026Sell(S)10$783.62$8K18K
Mar 2, 2026Sell(S)2$782.62$2K18K
Mar 2, 2026Sell(S)7$777.46$5K18K
Mar 2, 2026Sell(S)2$778.30$2K18K
Mar 2, 2026Sell(S)5$779.69$4K18K
Mar 2, 2026Sell(S)3$780.69$2K18K
Mar 2, 2026Sell(S)20$789.28$16K18K
Mar 2, 2026Sell(S)9$784.48$7K18K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001187443-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML